Elsevier Inc.

SHERPA: Unknown

People

  1. Wu
    Wu
  2. Adusumilli
    Adusumilli
  3. Zhang
    Zhang
  4. Barker
    Barker
  5. Gelblum
    Gelblum
  6. Travis
    Travis
  7. Yorke
    Yorke
  8. Chaft
    Chaft
  9. Gelb
    Gelb
  10. Jackson
    Jackson

Groups

  1. Radiation Oncology, Department of (7)
  2. Medical Physics (4)
  3. Radiotherapy Physics Service (4)
  4. Biostatistics Service (3)
  5. Epidemiology and Biostatistics (3)
  6. Sloan Kettering Institute Postdocs (3)
  7. Surgery (3)
  8. Melanoma Disease Management Team (2)
  9. Body Imaging Service (1)
  10. Department of Medicine (1)
Search Within
  1. "Andreas Rimner"
  2. "Abraham Wu"
  3. "Kelly Panchoo"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
Groups
  1. Radiation Oncology, Department of (7)
  2. Medical Physics (4)
  3. Radiotherapy Physics Service (4)
  4. Biostatistics Service (3)
  5. Epidemiology and Biostatistics (3)
  6. Sloan Kettering Institute Postdocs (3)

More Groups

People
  1. Abraham Wu (7)
  2. Andreas Rimner (7)
  3. Kelly Panchoo (7)
  4. Donata von Reibnitz (6)
  5. Ellen Yorke (4)
  6. Joseph Montecalvo (3)

More People

Years
  1. 2018 (1)
  2. 2017 (3)
  3. 2016 (3)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (4)
  2. Journal of Thoracic Oncology (2)
  3. Advances in Radiation Oncology (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition
    Journal Article

    von Reibnitz, D.; Chaft, J. E.; Wu, A. J.; Samstein, R.; Hellmann, M. D.; Plodkowski, A. J.; Zhang, Z.; Shi, W.; Dick-Godfrey, R.; Panchoo, K. H.; more...
    Advances in Radiation Oncology (2018)

    Fulltext@MSK | Save
  • PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy (SBRT)
    Meeting Abstract

    Lockney, N.; Yang, T. J.; Panchoo, K.; Gelblum, D.; Yorke, E.; Rimner, A.; Wu, A.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Histologic subtype of early-stage lung adenocarcinoma is a predictor of failure patterns after stereotactic body radiation therapy
    Meeting Abstract

    Leeman, J.; Rimner, A.; Montecalvo, J.; Hsu, M.; Zhang, Z.; Von Reibnitz, D.; Panchoo, K.; Yorke, E.; Adusumilli, P.; Travis, W.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Histologic subtype in core lung biopsies of early-stage lung adenocarcinoma is a prognostic factor for treatment response and failure patterns after stereotactic body radiation therapy
    Journal Article

    Leeman, J. E.; Rimner, A.; Montecalvo, J.; Hsu, M.; Zhang, Z.; von Reibnitz, D.; Panchoo, K.; Yorke, E.; Adusumilli, P. S.; Travis, W.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Safety of combining immune checkpoint inhibition and thoracic radiation therapy
    Meeting Abstract

    von Reibnitz, D.; Wu, A. J.; Barker, C. A.; Panchoo, K.; Rimner, A.
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save
  • Histologic subtype of early-stage lung adenocarcinoma predicts failure patterns in patients treated with stereotactic body radiation therapy
    Meeting Abstract

    Leeman, J. E.; Rimner, A.; Montecalvo, J.; von Reibnitz, D.; Panchoo, K.; Travis, W.; Adusumilli, P.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save
  • Planning target volume and FDG-PET maximum standardized uptake value, but not dosimetric parameters of target coverage, predict for local recurrence after stereotactic body radiation therapy for non-small cell lung cancer
    Meeting Abstract

    Wild, A. T.; Jackson, A.; Kohutek, Z. A.; Wu, A. J.; Gelblum, D.; von Reibnitz, D.; Gelb, E.; Panchoo, K.; Yan, M.; Yorke, E. D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save